Ruth Link‐Gelles

Centers for Disease Control and Prevention

Also affiliated with National Center for Immunization and Respiratory Diseases, United States Public Health Service Commissioned Officers Association

MedicineSocial Sciences

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 3%percentile

1.1Author DataRank

Indexed papers

2in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Clinical Epidemiology and Risk Factors for Critical Outcomes Among Vaccinated and Unvaccinated Adults Hospitalized With COVID-19—VISION Network, 10 States, June 2021–March 2023

Clinical Infectious Diseases(2023)10.1093/cid/ciad505

Top 22%

0.902DataRank

Top 22%27 citations

Patrick K. Mitchell, Victoria Lazariu, Manjusha Gaglani, Charlene McEvoy, Nicola P. Klein +41 more

Papers

Driven by 35 papers — median percentile 58. Top paper: “Immune escape and attenuated severity associated with the SARS-CoV-2 BA.2.86/JN.1 lineage”.

Immune escape and attenuated severity associated with the SARS-CoV-2 BA.2.86/JN.1 lineage

Nature Communications(2024)10.1038/s41467-024-52668-w

N/A

0.944DataRank · unranked

27 citations

Parag Mahale, Deborah E. Malden, Vennis Hong, Bradley K. Ackerson, Bruno Lewin +5 more

Clinical Epidemiology and Risk Factors for Critical Outcomes Among Vaccinated and Unvaccinated Adults Hospitalized With COVID-19—VISION Network, 10 States, June 2021–March 2023

Clinical Infectious Diseases(2023)10.1093/cid/ciad505

Top 22%

0.902DataRank

Top 22%27 citations

Patrick K. Mitchell, Victoria Lazariu, Manjusha Gaglani, Charlene McEvoy, Nicola P. Klein +41 more

Interim Recommendations from the Advisory Committee on Immunization Practices for the Use of Bivalent Booster Doses of COVID-19 Vaccines — United States, October 2022

MMWR Morbidity and Mortality Weekly Report(2022)10.15585/mmwr.mm7145a2

N/A

0.765DataRank · unranked

163 citations

Megan J. Wallace, Monica Godfrey, Lauren E. Roper, Elisha Hall, Katherine E. Fleming-Dutra +13 more

Estimates of Bivalent mRNA Vaccine Durability in Preventing COVID-19–Associated Hospitalization and Critical Illness Among Adults with and Without Immunocompromising Conditions — VISION Network, September 2022–April 2023

MMWR Morbidity and Mortality Weekly Report(2023)10.15585/mmwr.mm7221a3

N/A

0.695DataRank · unranked

102 citations

Zachary A. Weber, Sarah E. Reese, Amanda B. Payne, Manjusha Gaglani, Katherine Adams +30 more

Long-term Protection Associated With COVID-19 Vaccination and Prior Infection

JAMA(2022)10.1001/jama.2022.14660

N/A

0.510DataRank · unranked

29 citations

Ruth Link‐Gelles, Manish M. Patel, Mark W. Tenforde

Influenza Vaccine Effectiveness Against Hospitalizations and Emergency Department or Urgent Care Encounters for Children, Adolescents, and Adults During the 2023–2024 Season, United States

Clinical Infectious Diseases(2024)10.1093/cid/ciae597

N/A

0.470DataRank · unranked

22 citations

Emily L Reeves, Zachary A. Weber, Sara Y. Tartof, Nicola P. Klein, Kristin Dascomb +40 more

Screening and linkage to care for hepatitis C among inpatients in Georgia's national hospital screening program

Preventive Medicine(2020)10.1016/j.ypmed.2020.106153

N/A

0.457DataRank · unranked

20 citations

Muazzam Nasrullah, Amiran Gamkrelidze, Jessica M. Ray, Lia Gvinjilia, Tinatin Kuchuloria +10 more

Relative Effectiveness of Coronavirus Disease 2019 Vaccination and Booster Dose Combinations Among 18.9 Million Vaccinated Adults During the Early Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Period—United States, 1 January 2022 to 31 March 2022

Clinical Infectious Diseases(2023)10.1093/cid/ciad063

N/A

0.385DataRank · unranked

12 citations

Ryan E. Wiegand, Adewole C Oyalowo, Lara Bull–Otterson, Heartley Egwuogu, Trevor Thompson +12 more

Building the U.S. COVID-19 vaccine effectiveness program: Past successes and future directions

Vaccine(2023)10.1016/j.vaccine.2023.12.002

N/A

0.373DataRank · unranked

11 citations

Amadea Britton, Katherine E. Fleming-Dutra, Ruth Link‐Gelles

Effectiveness of 2023–2024 seasonal influenza vaccine against influenza-associated emergency department and urgent care encounters among pregnant and non-pregnant women of reproductive age

Vaccine(2025)10.1016/j.vaccine.2025.127483

N/A

0.241DataRank · unranked

4 citations

Kristin Dascomb, Stephanie A. Irving, Nicola P. Klein, Sara Y. Tartof, Shaun J. Grannis +39 more

Effectiveness of COVID-19 bivalent vaccination against SARS-CoV-2 infection among residents of US nursing homes, November 2022 – March 2023

Vaccine(2024)10.1016/j.vaccine.2024.07.013

Top 61%

0.241DataRank

Top 61%4 citations

Ryan E. Wiegand, Sujan Reddy, Arshiya Patel, James Baggs, Thomas Franceschini +5 more

Number needed to vaccinate with a COVID-19 booster to prevent a COVID-19-associated hospitalization during SARS-CoV-2 Omicron BA.1 variant predominance, December 2021–February 2022, VISION Network: a retrospective cohort study

The Lancet Regional Health - Americas(2023)10.1016/j.lana.2023.100530

N/A

0DataRank · unranked

15 citations

John Riddles, Elizabeth Rowley, Shaun J. Grannis, Manjusha Gaglani, Bruce Fireman +32 more

Impact of accounting for correlation between COVID-19 and influenza vaccination in a COVID-19 vaccine effectiveness evaluation using a test-negative design

Vaccine(2023)10.1016/j.vaccine.2023.11.025

N/A

0DataRank · unranked

12 citations

Allison Avrich Ciesla, Elizabeth Rowley, Zachary A. Weber, Sarah E. Reese, Toan C. Ong +10 more

Early Estimate of Nirsevimab Effectiveness for Prevention of Respiratory Syncytial Virus–Associated Hospitalization Among Infants Entering Their First Respiratory Syncytial Virus Season — New Vaccine Surveillance Network, October 2023–February 2024

MMWR Morbidity and Mortality Weekly Report(2024)10.15585/mmwr.mm7309a4

N/A

0DataRank · unranked

204 citations

Ayzsa Tannis, Ariana P. Toepfer, John V. Williams, Julie A. Boom, Janet A. Englund +40 more

Use of COVID-19 Vaccines for Persons Aged ≥6 Months: Recommendations of the Advisory Committee on Immunization Practices — United States, 2024–2025

MMWR Morbidity and Mortality Weekly Report(2024)10.15585/mmwr.mm7337e2

N/A

0DataRank · unranked

78 citations

Danielle Moulia, Monica Godfrey, Ruth Link‐Gelles, Lauren Roper, Fiona P. Havers +9 more

Interim Effectiveness of Updated 2023–2024 (Monovalent XBB.1.5) COVID-19 Vaccines Against COVID-19–Associated Emergency Department and Urgent Care Encounters and Hospitalization Among Immunocompetent Adults Aged ≥18 Years — VISION and IVY Networks, September 2023–January 2024

MMWR Morbidity and Mortality Weekly Report(2024)10.15585/mmwr.mm7308a5

N/A

0DataRank · unranked

77 citations

Amanda B. Payne, Wesley H. Self, Elizabeth Rowley, Kristin Dascomb, Malini B. DeSilva +94 more

Interim Effectiveness of Updated 2023–2024 (Monovalent XBB.1.5) COVID-19 Vaccines Against COVID-19–Associated Hospitalization Among Adults Aged ≥18 Years with Immunocompromising Conditions — VISION Network, September 2023–February 2024

MMWR Morbidity and Mortality Weekly Report(2024)10.15585/mmwr.mm7312a5

N/A

0DataRank · unranked

37 citations

Elizabeth Rowley, Malini B. DeSilva, Kristin Dascomb, Stephanie A. Irving, Nicola P. Klein +29 more

Use of Additional Doses of 2024–2025 COVID-19 Vaccine for Adults Aged ≥65 Years and Persons Aged ≥6 Months with Moderate or Severe Immunocompromise: Recommendations of the Advisory Committee on Immunization Practices — United States, 2024

MMWR Morbidity and Mortality Weekly Report(2024)10.15585/mmwr.mm7349a2

N/A

0DataRank · unranked

28 citations

Monica Godfrey, Ruth Link‐Gelles, Danielle Moulia, Christopher A. Taylor, Georgina Peacock +8 more

Nirsevimab Effectiveness Against Medically Attended Respiratory Syncytial Virus Illness and Hospitalization Among Alaska Native Children — Yukon-Kuskokwim Delta Region, Alaska, October 2023–June 2024

MMWR Morbidity and Mortality Weekly Report(2024)10.15585/mmwr.mm7345a1

N/A

0DataRank · unranked

16 citations

Sara Bressler, James W. Keck, Christine Desnoyers, Ellen Hodges, Gerald January +14 more

Advancing public health informatics during the COVID-19 pandemic: Lessons learned from a public–private partnership with pharmacies

Vaccine(2024)10.1016/j.vaccine.2024.01.092

N/A

0DataRank · unranked

7 citations

Roua El Kalach, Diana Yassanye, Ruth Link‐Gelles, Abdulhakeem Abayomi Olorukooba, Amee Khamar deMartino +11 more

Immune escape and attenuated severity associated with the SARS-CoV-2 BA.2.86/JN.1 lineage

medRxiv(2024)10.1101/2024.04.17.24305964

N/A

0DataRank · unranked

6 citations

Parag Mahale, Deborah E. Malden, Vennis Hong, Bradley K. Ackerson, Bruno Lewin +5 more

Interim Estimates of 2024–2025 COVID-19 Vaccine Effectiveness Among Adults Aged ≥18 Years — VISION and IVY Networks, September 2024–January 2025

MMWR Morbidity and Mortality Weekly Report(2025)10.15585/mmwr.mm7406a1

N/A

0DataRank · unranked

80 citations

Sean Chickery, A Webber, Toan C. Ong, Elizabeth Rowley, Malini B. DeSilva +94 more

Estimated 2023-2024 COVID-19 Vaccine Effectiveness in Adults

JAMA Network Open(2025)10.1001/jamanetworkopen.2025.17402

N/A

0DataRank · unranked

23 citations

Elizabeth Rowley, Stephanie A. Irving, Nicola P. Klein, Shaun J. Grannis, Toan C. Ong +34 more

Patterns in Prescribing and Dispensing Influenza Antivirals Among Adults With Influenza Presenting to Urgent Care and Emergency Department Settings: VISION Network, 2023–2024

Clinical Infectious Diseases(2025)10.1093/cid/ciaf178

N/A

0DataRank · unranked

3 citations

Shikha Garg, Sara Y. Tartof, Stephanie A. Irving, Malini B. DeSilva, Nicola P. Klein +28 more

Symptom reporting and vaccination status among SARS-CoV-2-positive encounters — Increasing Community Access to Testing, Treatment, and Response program, United States, September 2023–August 2024

Vaccine(2025)10.1016/j.vaccine.2025.127635

N/A

0DataRank · unranked

0 citations

Josephine Mak, Andrew Godoshian, Zachary Smith, Amadea Britton, Joseph D. Miller +2 more

Outbreaks and infection control breaches in health care settings: Considerations for patient notification

American Journal of Infection Control(2020)10.1016/j.ajic.2020.02.013

N/A

0DataRank · unranked

7 citations

Kiran M. Perkins, Ruth Link‐Gelles, Alexander J. Kallen, Priti R. Patel, Joseph F. Perz +1 more

Referrals of Infection Control Breaches to Public Health Authorities: Ambulatory Care Settings Experience, 2017

The Joint Commission Journal on Quality and Patient Safety(2020)10.1016/j.jcjq.2020.05.005

N/A

0DataRank · unranked

6 citations

Salome O. Chitavi, Kiran M. Perkins, Joseph F. Perz, Ruth Link‐Gelles, Jennifer Hoppe +4 more

Breastfeeding Duration and Cytomegalovirus Seroprevalence Among US Children Aged 1–5 Years: The National Health and Nutrition Examination Surveys, 2011–2012 and 2017–2018

Clinical Infectious Diseases(2020)10.1093/cid/ciaa1900

N/A

0DataRank · unranked

1 citations

Deanna Kruszon‐Moran, Ruth Link‐Gelles, Phili Wong, Sheila C. Dollard, Tatiana M. Lanzieri

Paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome in children: Paradoxical TB IRIS in Children

UNC Libraries(2020)10.17615/sn5q-fn52

N/A

0DataRank · unranked

0 citations

David R. Murdoch, Lee Fairlie, Shobna Sawry, Nasreen Mahomed, Charl Verwey +4 more

First-Dose COVID-19 Vaccination Coverage Among Skilled Nursing Facility Residents and Staff

JAMA(2021)10.1001/jama.2021.2352

N/A

0DataRank · unranked

32 citations

Anita Patel, Ruth Link‐Gelles, Radhika Gharpure

Effectiveness of COVID-19 mRNA Vaccines Against COVID-19–Associated Hospitalizations Among Immunocompromised Adults During SARS-CoV-2 Omicron Predominance — VISION Network, 10 States, December 2021—August 2022

MMWR Morbidity and Mortality Weekly Report(2022)10.15585/mmwr.mm7142a4

N/A

0DataRank · unranked

86 citations

Peter J. Embí, Matthew E. Levy, Manjusha Gaglani, Malini B. DeSilva, Brian E. Dixon +39 more

Use of Updated COVID-19 Vaccines 2023–2024 Formula for Persons Aged ≥6 Months: Recommendations of the Advisory Committee on Immunization Practices — United States, September 2023

MMWR Morbidity and Mortality Weekly Report(2023)10.15585/mmwr.mm7242e1

N/A

0DataRank · unranked

142 citations

Danielle Moulia, Ruth Link‐Gelles, Monica Godfrey, Josephine Mak, Morgan Najdowski +17 more

Interim Recommendations for Use of Bivalent mRNA COVID-19 Vaccines for Persons Aged ≥6 Months — United States, April 2023

MMWR Morbidity and Mortality Weekly Report(2023)10.15585/mmwr.mm7224a3

N/A

0DataRank · unranked

40 citations

Megan Wallace, Lauren E. Roper, Monica Godfrey, Hannah G. Rosenblum, Ruth Link‐Gelles +7 more

Development of COVID-19 vaccine policy — United States, 2020–2023

Vaccine(2023)10.1016/j.vaccine.2023.12.022

N/A

0DataRank · unranked

21 citations

Megan Wallace, Evelyn Twentyman, Danielle Moulia, Monica Godfrey, Ruth Link‐Gelles +11 more

Relationships Between Social Vulnerability and Coronavirus Disease 2019 Vaccination Coverage and Vaccine Effectiveness

Clinical Infectious Diseases(2023)10.1093/cid/ciad003

N/A

0DataRank · unranked

19 citations

Zachary A. Weber, Katie Allen, Edward Stenehjem, Stephanie A. Irving, Talia L. Spark +37 more

Ruth Link‐Gelles

Indexed papers

Top data-sharing exemplar

Papers